THRL — Target Healthcare Reit Income Statement
0.000.00%
- £577.44m
- £785.51m
- £69.55m
- 62
- 74
- 63
- 79
Annual income statement for Target Healthcare Reit, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 44.3 | 50 | 63.9 | 67.7 | 69.6 |
| Cost of Revenue | |||||
| Gross Profit | 44.2 | 49.9 | 63.7 | 67.6 | 69.4 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8.37 | 1.29 | 8.16 | 64.2 | -15.1 |
| Operating Profit | 35.9 | 48.7 | 55.7 | 3.56 | 84.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 31.6 | 43.9 | 49.1 | -6.57 | 73 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 31.6 | 43.9 | 49.1 | -6.57 | 73 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 31.6 | 43.9 | 49.1 | -6.57 | 73 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 31.6 | 43.9 | 49.1 | -6.57 | 73 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.074 | 0.094 | 0.082 | -0.01 | 0.118 |
| Dividends per Share |